Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...

CVS Health (CVS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...